Skip to main content
NCBI home page
Quality & Safety in Health Care logoLink to Quality & Safety in Health Care
. 2005 Apr;14(2):93–98. doi: 10.1136/qshc.2003.007914

Use of a systematic risk analysis method to improve safety in the production of paediatric parenteral nutrition solutions

P Bonnabry 1, L Cingria 1, F Sadeghipour 1, H Ing 1, C Fonzo-Christe 1, R Pfister 1
PMCID: PMC1743981  PMID: 15805453

Abstract

Background: Until recently, the preparation of paediatric parenteral nutrition formulations in our institution included re-transcription and manual compounding of the mixture. Although no significant clinical problems have occurred, re-engineering of this high risk activity was undertaken to improve its safety. Several changes have been implemented including new prescription software, direct recording on a server, automatic printing of the labels, and creation of a file used to pilot a BAXA MM 12 automatic compounder. The objectives of this study were to compare the risks associated with the old and new processes, to quantify the improved safety with the new process, and to identify the major residual risks.

Methods: A failure modes, effects, and criticality analysis (FMECA) was performed by a multidisciplinary team. A cause-effect diagram was built, the failure modes were defined, and the criticality index (CI) was determined for each of them on the basis of the likelihood of occurrence, the severity of the potential effect, and the detection probability. The CIs for each failure mode were compared for the old and new processes and the risk reduction was quantified.

Results: The sum of the CIs of all 18 identified failure modes was 3415 for the old process and 1397 for the new (reduction of 59%). The new process reduced the CIs of the different failure modes by a mean factor of 7. The CI was smaller with the new process for 15 failure modes, unchanged for two, and slightly increased for one. The greatest reduction (by a factor of 36) concerned re-transcription errors, followed by readability problems (by a factor of 30) and chemical cross contamination (by a factor of 10). The most critical steps in the new process were labelling mistakes (CI 315, maximum 810), failure to detect a dosage or product mistake (CI 288), failure to detect a typing error during the prescription (CI 175), and microbial contamination (CI 126).

Conclusions: Modification of the process resulted in a significant risk reduction as shown by risk analysis. Residual failure opportunities were also quantified, allowing additional actions to be taken to reduce the risk of labelling mistakes. This study illustrates the usefulness of prospective risk analysis methods in healthcare processes. More systematic use of risk analysis is needed to guide continuous safety improvement of high risk activities.

Full Text

The Full Text of this article is available as a PDF (96.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allwood M. C. Pharmaceutical aspects of parenteral nutrition: from now to the future. Nutrition. 2000 Jul-Aug;16(7-8):615–618. doi: 10.1016/s0899-9007(00)00337-3. [DOI] [PubMed] [Google Scholar]
  2. Burgmeier Jean. Failure mode and effect analysis: an application in reducing risk in blood transfusion. Jt Comm J Qual Improv. 2002 Jun;28(6):331–339. doi: 10.1016/s1070-3241(02)28033-5. [DOI] [PubMed] [Google Scholar]
  3. Cohen M. R., Senders J., Davis N. M. Failure mode and effects analysis: a novel approach to avoiding dangerous medication errors and accidents. Hosp Pharm. 1994 Apr;29(4):319–330. [PubMed] [Google Scholar]
  4. Combeau D., Rey J. B., Fontan J. E., Nouaille-Degorce B., Brion F. Baxa MicroMacrocompounder for parenteral nutrition solutions in a pediatric hospital. PDA J Pharm Sci Technol. 1999 Sep-Oct;53(5):226–230. [PubMed] [Google Scholar]
  5. Combeau D., Rey J. B., Rieutord A., Fontan J. E., Arnaud P., Brion F. Accuracy of two filling systems for parenteral nutrient solutions. Am J Health Syst Pharm. 1998 Aug 1;55(15):1606–1610. doi: 10.1093/ajhp/55.15.1606. [DOI] [PubMed] [Google Scholar]
  6. DeRosier Joseph, Stalhandske Erik, Bagian James P., Nudell Tina. Using health care Failure Mode and Effect Analysis: the VA National Center for Patient Safety's prospective risk analysis system. Jt Comm J Qual Improv. 2002 May;28(5):248-67, 209. doi: 10.1016/s1070-3241(02)28025-6. [DOI] [PubMed] [Google Scholar]
  7. DiDonato L. J. Use of the handheld programmable calculator in the preparation of TPN solutions. Hosp Pharm. 1983 Oct;18(10):526-8, 531-3. [PubMed] [Google Scholar]
  8. Dickson L. B., Somani S. M., Herrmann G., Abramowitz P. W. Automated compounder for adding ingredients to parenteral nutrient base solutions. Am J Hosp Pharm. 1993 Apr;50(4):678–682. [PubMed] [Google Scholar]
  9. Driscoll D. F., Bacon M., Provost P. S., Bistrian B. R. Automated compounders for parenteral nutrition admixtures. JPEN J Parenter Enteral Nutr. 1994 Jul-Aug;18(4):385–386. doi: 10.1177/014860719401800427. [DOI] [PubMed] [Google Scholar]
  10. Fletcher C. E. Failure mode and effects analysis. An interdisciplinary way to analyze and reduce medication errors. J Nurs Adm. 1997 Dec;27(12):19–26. doi: 10.1097/00005110-199712000-00008. [DOI] [PubMed] [Google Scholar]
  11. Flynn E. A., Pearson R. E., Barker K. N. Observational study of accuracy in compounding i.v. admixtures at five hospitals. Am J Health Syst Pharm. 1997 Apr 15;54(8):904–912. doi: 10.1093/ajhp/54.8.904. [DOI] [PubMed] [Google Scholar]
  12. Heird W. C., Driscoll J. M., Jr, Schullinger J. N., Grebin B., Winters R. W. Intravenous alimentation in pediatric patients. J Pediatr. 1972 Mar;80(3):351–372. doi: 10.1016/s0022-3476(72)80492-x. [DOI] [PubMed] [Google Scholar]
  13. Hergon E., Crespeau H., Rouger P. Modes de défaillance du processus transfusionnel. Intérêt de l'analyse prévisionnelle de sûreté de fonctionnement. Transfus Clin Biol. 1994;1(5):379–386. doi: 10.1016/s1246-7820(06)80020-0. [DOI] [PubMed] [Google Scholar]
  14. Hergon E., Rouger P., Garnerin P. La prévention des défaillances du processus transfusionnel. Transfus Clin Biol. 1994;1(6):455–465. doi: 10.1016/s1246-7820(06)80030-3. [DOI] [PubMed] [Google Scholar]
  15. Horn Werner, Popow Christian, Miksch Silvia, Kirchner Lieselotte, Seyfang Andreas. Development and evaluation of VIE-PNN, a knowledge-based system for calculating the parenteral nutrition of newborn infants. Artif Intell Med. 2002 Mar;24(3):217–228. doi: 10.1016/s0933-3657(01)00105-1. [DOI] [PubMed] [Google Scholar]
  16. Johnson R., Coles B. J., Tribble D. A. Accuracy of three automated compounding systems determined by end-product laboratory testing and comparison with manual preparation. Am J Health Syst Pharm. 1998 Jul 15;55(14):1503–1507. doi: 10.1093/ajhp/55.14.1503. [DOI] [PubMed] [Google Scholar]
  17. Leape L. L. A systems analysis approach to medical error. J Eval Clin Pract. 1997 Aug;3(3):213–222. doi: 10.1046/j.1365-2753.1997.00006.x. [DOI] [PubMed] [Google Scholar]
  18. MacMahon P. Prescribing and formulating neonatal intravenous feeding solutions by microcomputer. Arch Dis Child. 1984 Jun;59(6):548–552. doi: 10.1136/adc.59.6.548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Marey A., Coupez B., Gruca L., Vannier V., Renom P., Wibaut B., Rugeri L., Cossement C., Cosson A. Impact d'une démarche qualité en sécurité transfusionnelle sur la prescription, l'optimisation des circuits, la traçabilité. Expérience du CHRU de Lille. Transfus Clin Biol. 1997 Oct;4(5):469–484. doi: 10.1016/s1246-7820(97)80065-1. [DOI] [PubMed] [Google Scholar]
  20. Marx D. A., Slonim A. D. Assessing patient safety risk before the injury occurs: an introduction to sociotechnical probabilistic risk modelling in health care. Qual Saf Health Care. 2003 Dec;12 (Suppl 2):ii33–ii38. doi: 10.1136/qhc.12.suppl_2.ii33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. May F., Robbins G. A computer program for parenteral nutrition solution preparation. JPEN J Parenter Enteral Nutr. 1978 Nov;2(5):646–651. doi: 10.1177/014860717800200505. [DOI] [PubMed] [Google Scholar]
  22. McLellan N. Microcomputer organization of parenteral nutrition in the neonate. J Clin Hosp Pharm. 1983 Jun;8(2):147–151. doi: 10.1111/j.1365-2710.1983.tb01045.x. [DOI] [PubMed] [Google Scholar]
  23. McNally K. M., Page M. A., Sunderland V. B. Failure-mode and effects analysis in improving a drug distribution system. Am J Health Syst Pharm. 1997 Jan 15;54(2):171–177. doi: 10.1093/ajhp/54.2.171. [DOI] [PubMed] [Google Scholar]
  24. Mitchell K. A., Jones E. A., Meguid M. M., Curtas S. Standardized TPN order form reduces staff time and potential for error. Nutrition. 1990 Nov-Dec;6(6):457–460. [PubMed] [Google Scholar]
  25. Picart D., Guillois B., Nevo L., Alix D. A program for parenteral and combined parenteral and enteral nutrition of neonates and children in an intensive care unit. Intensive Care Med. 1989;15(4):279–282. doi: 10.1007/BF00271068. [DOI] [PubMed] [Google Scholar]
  26. Pichard C., Mühlebach S., Maisonneuve N., Sierro C. Prospective survey of parenteral nutrition in Switzerland: a three-year nation-wide survey. Clin Nutr. 2001 Aug;20(4):345–350. doi: 10.1054/clnu.2001.0428. [DOI] [PubMed] [Google Scholar]
  27. Saizy-Callaert S., Causse R., Thébault A., Chouaïd C. Analyse des modes de défaillances, de leurs effets et de leur criticité: amélioration de la prescription des médicaments à l'hôpital. Therapie. 2001 Sep-Oct;56(5):525–531. [PubMed] [Google Scholar]
  28. Santell J. P., Kamalich R. F. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals and home infusion facilities--1995. Am J Health Syst Pharm. 1996 Nov 1;53(21):2591–2605. doi: 10.1093/ajhp/53.21.2591. [DOI] [PubMed] [Google Scholar]
  29. Schloerb P. R. Electronic parenteral and enteral nutrition. JPEN J Parenter Enteral Nutr. 2000 Jan-Feb;24(1):23–29. doi: 10.1177/014860710002400123. [DOI] [PubMed] [Google Scholar]
  30. Storm H. M., Young S. L., Sandler R. H. Development of pediatric and neonatal parenteral nutrition order forms. Nutr Clin Pract. 1995 Apr;10(2):54–59. doi: 10.1177/011542659501000254. [DOI] [PubMed] [Google Scholar]
  31. Vandenplas Y., De Belder B., Bougatef A., Sacré L., De Clercq H. Computerized prescription of total parenteral nutrition in pediatrics. Acta Anaesthesiol Belg. 1987;38(1):59–62. [PubMed] [Google Scholar]
  32. Williams E., Talley R. The use of failure mode effect and criticality analysis in a medication error subcommittee. Hosp Pharm. 1994 Apr;29(4):331-2, 334-6, 339. [PubMed] [Google Scholar]
  33. Willis G. Failure modes and effects analysis in clinical engineering. J Clin Eng. 1992 Jan-Feb;17(1):59–63. doi: 10.1097/00004669-199201000-00022. [DOI] [PubMed] [Google Scholar]

Articles from Quality & safety in health care are provided here courtesy of BMJ Publishing Group

RESOURCES